Research. Topical anal microbicide reduces risk of HIV transmission in trial.
D000287:Administration, Topical; D001003:Anal Canal; D000813:Anilides / Q000008:administration & dosage*; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005663:Furans / Q000008:administration & dosage*; D005782:Gels; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D013854:Thioamides
D000813:Anilides; D019380:Anti-HIV Agents; D005663:Furans; D005782:Gels; D013854:Thioamides; C100668:UC-781